萧条(经济学)
焦虑
心理干预
心理健康
精神科
医学
数字健康
临床心理学
心理学
干预(咨询)
梅德林
生活质量(医疗保健)
情感(语言学)
作者
Fatma Magdi Ibrahim,Iliya Petkov,Mohammed Musaed Al-Jabri,Ahmad Hammoud,Mohamad Ahmad Saleem Khasawneh,Sirwan Khaled Ahmed,Ghada Shahrour
摘要
ABSTRACT Background Older adults face growing risks of depression and anxiety, yet stigma, comorbidities, cost, and limited access impede receipt of conventional care. Digital mental health interventions (DMHIs), including immersive virtual reality (VR), exergaming, and mobile apps, may reduce these barriers. Aim To evaluate the efficacy of DMHIs in reducing depressive and anxiety symptoms among adults aged ≥ 50 years. Methods We conducted a PRISMA adherent systematic review and meta‐analysis of randomized controlled trials. Interventions included immersive VR, exergaming/physical digital platforms, mobile applications, and digital cognitive training. Standardized mean differences (SMDs) were pooled with random effects models; heterogeneity was assessed with I 2 . Results Nineteen RCTs ( n = 718; mean ages 50.9–84.7 years) met inclusion criteria. Across studies, DMHIs significantly reduced depressive symptoms (SMD = −0.656, 95% CI = −0.932 to −0.380; p < 0.001) and anxiety symptoms (SMD = −0.559, 95% CI = −0.740 to −0.380; p < 0.0001). Immersive and physically engaging modalities (e.g., VR, exergaming) outperformed app‐based approaches. Heterogeneity ranged from moderate to high ( I 2 ≈ 69.6%–97%). Linking Evidence to Action Offer DMHIs : especially VR or exergaming when access to in‐person therapy is limited or as an adjunct to usual care. Provide brief onboarding and, when feasible, caregiver support to boost adherence and confidence with technology. Select or configure age‐friendly interfaces (e.g., large fonts, simple navigation) to address common usability barriers. Integrate DMHIs into stepped‐care or rehabilitation pathways and monitor outcomes with validated tools (e.g., GDS, STAI). Address equity by supplying devices/connectivity solutions and consider cost‐effectiveness and long‐term engagement in implementation plans. Trial Registration: PROSPERO ID: CRD420250655153
科研通智能强力驱动
Strongly Powered by AbleSci AI